Cargando…

UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients

BACKGROUND: The uncoupling proteins (UCPs) are critical genes associated with tumorigenesis and chemoresistance. However, little is known about the molecular mechanism of the UCPs in ovarian cancer (OV). MATERIAL AND METHODS: UCPs expression analysis was conducted using Gene Expression Profiling Int...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jinfa, Wang, Guilian, Liao, Kedan, Xie, Ning, Deng, Kaixian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800348/
https://www.ncbi.nlm.nih.gov/pubmed/35090503
http://dx.doi.org/10.1186/s13048-022-00951-z
_version_ 1784642240800358400
author Huang, Jinfa
Wang, Guilian
Liao, Kedan
Xie, Ning
Deng, Kaixian
author_facet Huang, Jinfa
Wang, Guilian
Liao, Kedan
Xie, Ning
Deng, Kaixian
author_sort Huang, Jinfa
collection PubMed
description BACKGROUND: The uncoupling proteins (UCPs) are critical genes associated with tumorigenesis and chemoresistance. However, little is known about the molecular mechanism of the UCPs in ovarian cancer (OV). MATERIAL AND METHODS: UCPs expression analysis was conducted using Gene Expression Profiling Interactive Analysis (GEPIA), and its potential in clinical prognosis was analyzed using Kaplan- Meier analyses. The influence of UCPs on immune infiltration was analyzed by TIMER. In addition, the correlation between UCPs expression and molecular mechanisms was investigated by TIMER and Cancer Single-cell State Atlas (CancerSEA). RESULTS: UCP1, UCP2, UCP3 and UCP5 expression levels correlated with a favorable prognosis and tumor progression. Moreover, UCP1 expression correlated to several immune cell markers and regulated tumorigenesis, such as tumor invasion, EMT, metastasis and DNA repair. In addition, UCP1 potentially involved in genes expression of SNAI2, MMP2, BRCA1 and PARP1. CONCLUSIONS: These results implied a critical role of UCP1 in the prognosis and immune infiltration of ovarian cancer. In addition, UCP1 expression participated in regulating multiple oncogenes and tumorigenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13048-022-00951-z.
format Online
Article
Text
id pubmed-8800348
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88003482022-02-02 UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients Huang, Jinfa Wang, Guilian Liao, Kedan Xie, Ning Deng, Kaixian J Ovarian Res Research BACKGROUND: The uncoupling proteins (UCPs) are critical genes associated with tumorigenesis and chemoresistance. However, little is known about the molecular mechanism of the UCPs in ovarian cancer (OV). MATERIAL AND METHODS: UCPs expression analysis was conducted using Gene Expression Profiling Interactive Analysis (GEPIA), and its potential in clinical prognosis was analyzed using Kaplan- Meier analyses. The influence of UCPs on immune infiltration was analyzed by TIMER. In addition, the correlation between UCPs expression and molecular mechanisms was investigated by TIMER and Cancer Single-cell State Atlas (CancerSEA). RESULTS: UCP1, UCP2, UCP3 and UCP5 expression levels correlated with a favorable prognosis and tumor progression. Moreover, UCP1 expression correlated to several immune cell markers and regulated tumorigenesis, such as tumor invasion, EMT, metastasis and DNA repair. In addition, UCP1 potentially involved in genes expression of SNAI2, MMP2, BRCA1 and PARP1. CONCLUSIONS: These results implied a critical role of UCP1 in the prognosis and immune infiltration of ovarian cancer. In addition, UCP1 expression participated in regulating multiple oncogenes and tumorigenesis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13048-022-00951-z. BioMed Central 2022-01-28 /pmc/articles/PMC8800348/ /pubmed/35090503 http://dx.doi.org/10.1186/s13048-022-00951-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Huang, Jinfa
Wang, Guilian
Liao, Kedan
Xie, Ning
Deng, Kaixian
UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
title UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
title_full UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
title_fullStr UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
title_full_unstemmed UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
title_short UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
title_sort ucp1 modulates immune infiltration level and survival outcome in ovarian cancer patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800348/
https://www.ncbi.nlm.nih.gov/pubmed/35090503
http://dx.doi.org/10.1186/s13048-022-00951-z
work_keys_str_mv AT huangjinfa ucp1modulatesimmuneinfiltrationlevelandsurvivaloutcomeinovariancancerpatients
AT wangguilian ucp1modulatesimmuneinfiltrationlevelandsurvivaloutcomeinovariancancerpatients
AT liaokedan ucp1modulatesimmuneinfiltrationlevelandsurvivaloutcomeinovariancancerpatients
AT xiening ucp1modulatesimmuneinfiltrationlevelandsurvivaloutcomeinovariancancerpatients
AT dengkaixian ucp1modulatesimmuneinfiltrationlevelandsurvivaloutcomeinovariancancerpatients